The value of FGF9 as a novel biomarker in the diagnosis of prostate cancer
- Type
- Retraction
- Notice date
- 1/11/2021 0:00
- Journal
- Artificial Cells, Nanomedicine, and Biotechnology
- Publisher
- Taylor and Francis
- Notice DOI
- 10.1080/21691401.2020.1836837
- Original paper DOI
- 10.1080/21691401.2019.1620250